Stay updated on PRTX-100-202 Study in ITP Clinical Trial
Sign up to get notified when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.

Latest updates to the PRTX-100-202 Study in ITP Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for the PRTX-100 study in adults with immune thrombocytopenia is now displayed instead of an error page. It provides the study’s design, participant criteria, locations, and outcome measures.SummaryDifference48%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedAn NIH-wide notice about terminology changes appears above the page, and the site revision number is updated from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now renders a 403 Forbidden error page with the site header and footer visible, replacing the previous study record content. This indicates restricted access to the content at this URL.SummaryDifference17%

- Check58 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating an administrative update to the ClinicalTrials.gov record. This reflects backend maintenance rather than changes to study information.SummaryDifference0.1%

Stay in the know with updates to PRTX-100-202 Study in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.